Ajit Singh

Ajit Singh focuses on early-stage Technology and Life Science investments. He currently represents Artiman on the Boards of Aditazz, CardioDx, Click Diagnostics, CORE Diagnostics, medECUBE and OncoStem.

Ajit is also a Consulting Professor in the School of Medicine at Stanford University and serves on the Board of Directors of Max Healthcare based in New Delhi, India.

Prior to joining Artiman, Ajit was the President and CEO of BioImagene, a Digital Pathology company specializing in Cancer Diagnostics, based in Sunnyvale, CA. BioImagene was acquired by Roche in September 2010. Before BioImagene, Ajit spent nearly twenty years at Siemens in various roles, most recently as the Chief Executive Officer of the Digital Radiology and Medical Informatics business of Siemens Healthcare, based in Germany. From 2001 to 2006, Ajit was the President and CEO of the Oncology Care Systems Group of Siemens, with global headquarters in Concord, California. Between 1996 and 2001, Ajit held the positions of Group Vice President of Siemens e-Health, and Vice President of Siemens Health Services based in Princeton, NJ, where he led the company’s Healthcare IT business and Consulting Practice. Before transitioning to these business responsibilities, Ajit spent several years in R&D and academia. From 1989 to 1995, he was at Siemens Corporate Research in Princeton, responsible for research in the areas of artificial intelligence, robotics, computer vision, and image analysis. During this time, he concurrently served on the faculty at Princeton University.

Ajit has a Ph.D. in Computer Science from Columbia University, a master’s degree in Computer Engineering from Syracuse University and a bachelor’s degree in Electrical Engineering from Banaras Hindu University, India. He has published two books and numerous refereed articles, and holds five patents.